Treatment outcomes of pulpotomy versus pulpectomy in vital primary molars diagnosed with symptomatic irreversible pulpitis: protocol for a non-inferiority randomised controlled tri... by Nebu Philip (14779318)

“…The secondary outcome evaluated will be the immediate (24 h and 7 d) post-operative pain relief afforded by the two treatment interventions.…”

Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐A... by Mushood Ahmed (19231379)

“…This study aimed to evaluate the safety and efficacy of insulin icodec compared with those of once‐daily glargine U100.…”

1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH by Elhilali, Mostafa

“…INTRODUCTION AND OBJECTIVES Evaluate the potential use of PSA-targeted therapy for the treatment of LUTS 2ry to BPH, through assessment of the safety and tolerability of PRX302, a proaerolysin toxin genetically modified to be activated by PSA. …”
Get full text
Get full text
Get full text
Get full text

Bevacizumab for neovascular age-related macular degeneration (ABC trial) by Ghazi, Nicola G.

Get full text
Get full text
Get full text
Get full text

Participant characteristics are poorly reported in exercise trials in tendinopathy: A systematic review by Seán Mc Auliffe (8909972)

“…<h3>Objective</h3> <p>To evaluate the reporting of eligibility criteria and baseline participant characteristics in randomised controlled trials investigating the effects of exercise interventions in tendinopathy.…”

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19 by Matli, Kamal

“…Sufficiently powered randomised controlled trials are needed to further evaluate the safety and efficacy of combining antiplatelet and anticoagulants agents or using TAC in the management of patients with COVID-19 infection.…”
Get full text
Get full text
Get full text
Get full text

Effectiveness of lipid‐based nutrient supplementation during the first 1000 days of life for early childhood development: A community‐based trial from Pakistan by Ayesha Imtiaz (18858232)

“…Age‐appropriate lipid‐based nutrient supplements and health education (sessions conducted in the households) were given to pregnant women and their born children (6–23 months) in the intervention arm (<i>n</i> = 40 clusters) versus health education only in the control arm (<i>n</i> = 40 clusters) to evaluate its effect on child development. The first and second developmental assessments were completed at ~24 months (<i>n</i> = 689) and ~32 months (<i>n</i> = 608), respectively, using the Caregiver‐Reported Early Development Instrument Long form. …”